Shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Get Free Report) crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $1.12 and traded as high as $1.19. AquaBounty Technologies shares last traded at $1.15, with a volume of 102,097 shares.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, September 14th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, AquaBounty Technologies presently has an average rating of “Sell”.
Get Our Latest Stock Analysis on AQB
AquaBounty Technologies Trading Up 3.6%
The company has a market cap of $6.00 million, a P/E ratio of -1.40 and a beta of 1.48. The firm’s 50 day moving average price is $1.12 and its 200-day moving average price is $1.01.
AquaBounty Technologies (NASDAQ:AQB – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.26) EPS for the quarter.
Hedge Funds Weigh In On AquaBounty Technologies
A hedge fund recently bought a new position in AquaBounty Technologies stock. BlackRock Inc. bought a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 47,528 shares of the company’s stock, valued at approximately $51,000. BlackRock Inc. owned 0.92% of AquaBounty Technologies as of its most recent filing with the Securities and Exchange Commission. 8.92% of the stock is owned by institutional investors.
AquaBounty Technologies Company Profile
AquaBounty Technologies, Inc is a biotechnology and aquaculture company focused on developing land-based, land-based recirculating aquaculture systems (RAS) to produce Atlantic salmon. The company’s approach is designed to support year-round fish production while reducing reliance on ocean-based farming and limiting water use through treatment and reuse.
AquaBounty’s principal product is AquAdvantage salmon, a genetically engineered Atlantic salmon developed to reach market size more efficiently than conventional Atlantic salmon.
Read More
- Five stocks we like better than AquaBounty Technologies
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
